Publications by Emeritus Professor David Bates - ePrints

Browsing publications by Emeritus Professor David Bates.

Newcastle Authors	Title	Year
Professor Sarah Slight Emeritus Professor David Bates Dr Clare Tolley	The effect of digital antimicrobial stewardship programmes on antimicrobial usage, length of stay, mortality and cost	2023
Professor Sarah Slight Emeritus Professor David Bates Neil Watson	Electronic prescribing systems in hospitals to improve medication safety: A multimethods research programme	2022
Dr Clare Tolley Professor Sarah Slight Professor Andy Husband Neil Watson Emeritus Professor David Bates et al.	Improving medication-related clinical decision support	2018
Professor Sarah Slight Emeritus Professor David Bates	Medication-related clinical decision support alert overrides in inpatients	2018
Emeritus Professor David Bates	Lord Walton of Detchant Obituary	2016
Emeritus Professor David Bates	A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy	2014
Emeritus Professor David Bates	A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)	2013
Emeritus Professor David Bates	Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool	2013
Emeritus Professor David Bates	Effects of natalizumab treatment on freedom from disease activity by baseline characteristics in AFFIRM	2013
Emeritus Professor David Bates	A Risk-Benefit Analysis of Natalizumab Across PML Risk Sub-Groups in Patients with Relapsing-Remitting Multiple Sclerosis	2012
Emeritus Professor David Bates	Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Replapsing-Remitting Multiple Sclerosis in Sweden	2012
Emeritus Professor David Bates	Treatment effect of natalizumab on relapse outcomes in multiple sclerosis patients despite ongoing MRI activity	2012
Emeritus Professor David Bates	Long-term outcomes in patients with multiple sclerosis	2011
Emeritus Professor David Bates	Methodology and validation of urinary incontinence in multiple sclerosis screening tool	2011
Emeritus Professor David Bates	Registry data	2011
Emeritus Professor David Bates	Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials	2011
Emeritus Professor David Bates	The value of uniform MRI protocols in the management and treatment of MS in the West	2010
Emeritus Professor David Bates	Invited lecture 6: The future of therapy in multiple sclerosis	2009
Emeritus Professor David Bates Professor John Isaacs	Should neurologists wait and see or see and treat RRMS?	2009
Emeritus Professor David Bates	Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode	2009
Emeritus Professor David Bates	Future therapies in multiple sclerosis	2008
Emeritus Professor David Bates	Future therapies in multiple sclerosis	2008
Dr Vanessa Hogan Dr Kathleen White Emeritus Professor David Bates Emeritus Professor Doug Turnbull Dr Philip Nichols et al.	An increase in axonal mitochondrial density may play a role in axonal loss following myelin degeneration in the Plp1 mouse model of demyelination	2007
Professor Patrick Chinnery Dr Douglas Crompton Dr Margaret Jackson Emeritus Professor David Bates Professor Sir John Burn et al.	Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation	2007
Emeritus Professor David Bates	Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring	2007
Emeritus Professor David Bates	Can somatosensory evoked potentials and neuron-specific enolase reliably predict outcome in postanoxic coma? Commentary	2006
Dr Helen Andrews Dr Kathryn White Emeritus Professor David Bates Emeritus Professor Doug Turnbull Dr Philip Nichols et al.	Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse	2006
Emeritus Professor David Bates	Natalizumab in relapsing multiple sclerosis: appropriate patient selection, management guidelines, and a diagnostic algorithm for the differential diagnosis of new neurologic signs or symptoms	2006
Dr Helen Andrews Dr Kathleen White Christopher Thomson Emeritus Professor David Bates Emeritus Professor Doug Turnbull et al.	A role for mitochondria in axonal loss in multiple sclerosis: studies in the Shiverer mouse model	2005
Dr Philip Nichols Dr Helen Andrews Dr Kathleen White Emeritus Professor David Bates Emeritus Professor Doug Turnbull et al.	A role for mitochondria in chronic axonal loss in multiple sclerosis: Studies at early and late time points in the shiverer mouse model	2005
Dr Helen Andrews Dr Kathleen White Emeritus Professor David Bates Emeritus Professor Doug Turnbull Dr Philip Nichols et al.	A role for mitochondria in chronic axonal loss in multiple sclerosis: studies at early and late time points in the shiverer mouse model	2005
Emeritus Professor David Bates	Disease management in multiple sclerosis	2005
Emeritus Professor David Bates	Disease management in multiple sclerosis	2005
Dr Helen Andrews Dr Kathleen White Emeritus Professor David Bates Emeritus Professor Doug Turnbull Dr Philip Nichols et al.	Mitochondria and axonal loss in multiple sclerosis: the missing link?	2005
Dr Helen Andrews Dr Kathleen White Christopher Thomson Emeritus Professor David Bates Emeritus Professor Doug Turnbull et al.	Mitochondria and axonal loss in multiple sclerosis: the shiverer mouse as a model of secondary progressive MS	2005
Dr Helen Andrews Dr Philip Nichols Emeritus Professor David Bates Emeritus Professor Doug Turnbull	Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis	2005
Dr Douglas Crompton Professor Patrick Chinnery Emeritus Professor David Bates Dr Timothy Walls Dr Margaret Jackson et al.	Spectrum of movement disorders in neuroferritinopathy	2005
Dr Daniel Birchall Emeritus Professor David Bates Emerita Professor Katherine Bushby Professor Patrick Chinnery	Subclinical semitendinosus and obturator externus involvement defines an autosomal dominant myopathy with early respiratory failure	2005
Emeritus Professor David Bates	The vegetative state and the Royal College of Physicians guidance	2005
Professor Mark Baker Professor John Isaacs Dr Peter Fawcett Emeritus Professor David Bates	Treatment of stiff person syndrome with rituximab	2005
Dr Martin Barron Philip Griffiths Emeritus Professor Doug Turnbull Emeritus Professor David Bates Dr Philip Nichols et al.	The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head	2004
Emeritus Professor David Bates	The way forward to treatment optimisation in multiple sclerosis: Introduction	2004
Dr Martin Barron Emeritus Professor Doug Turnbull Emeritus Professor David Bates Dr Philip Nichols	[abstract] Neuronal loss in Multiple Sclerosis: Role of Mitochondria in the Axonal response to Demyelination	2003
Dr Hazel Powell Dr Sally Lynch Emeritus Professor David Bates Dr Ann Curtis	A deletion within the frataxin gene, combined with a GAA expansion mutation causes atypical Friedreich ataxia	2003
Emeritus Professor David Bates	The effectiveness of Natalizumab on MRI outcome measures in patients with relapsing multiple sclerosis	2003
Emeritus Professor David Bates	The vegetative state: guidance on diagnosis and management - A report of a working party of the Royal College of Physicians	2003
Professor Patrick Chinnery Andrew Curtis Constanze Fey Dr Margaret Jackson Emeritus Professor David Bates et al.	Neuroferritinopathy	2002
Dr Douglas Crompton Professor Patrick Chinnery Constanze Fey Andrew Curtis Dr Christopher Morris et al.	Neuroferritinopathy: A window on the role of iron in neurodegeneration	2002
Professor Patrick Chinnery Dr Timothy Walls Professor Michael Hanna Emeritus Professor David Bates Dr Peter Fawcett et al.	Normokalemic periodic paralysis revisited: Does it exist?	2002
Andrew Curtis Constanze Fey Dr Christopher Morris Professor Laurence Bindoff Professor Patrick Chinnery et al.	Mutation in ferritin light chain causes dominant adult onset neurodegeneration	2001
Andrew Curtis Constanze Fey Dr Christopher Morris Professor Laurence Bindoff Professor Patrick Chinnery et al.	Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease	2001
Emeritus Professor David Bates	PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS	2001
Emeritus Professor David Bates	Randomized controlled trial of interferon-beta-1a in secondary progressive MS - Clinical results	2001
Emeritus Professor David Bates	The prognosis of medical coma	2001
Professor Sir John Burn Andrew Curtis Dr Matthew Jackson Constanze Fey Emeritus Professor David Bates et al.	A novel autosomal dominant basal ganglia degeneration with cavitation on 19q can mimic Parkinson's disease and Huntington's disease	2000
Dr David Parkin Emeritus Professor David Bates	Costs and quality of life in multiple sclerosis: a cross-sectional observational study in the UK	2000
Emeritus Professor David Bates Professor Simon Thomas	Multiple sclerosis: care needs for 2000 and beyond	2000
Dr David Parkin Dr Ann Jacoby Paul McNamee Paul Miller Professor Simon Thomas et al.	Treatment of multiple sclerosis with interferon β: An appraisal of cost-effectiveness and quality of life	2000
Professor David Burn Emeritus Professor David Bates	Quantitative analysis of MRI signal intensity in new variant Creutzfeldt-Jakob disease	1999
Professor Robert Taylor Professor Patrick Chinnery Emeritus Professor David Bates Dr Margaret Jackson Dr Margaret Johnson et al.	A novel mitochondrial DNA point mutation in the tRNA(Ile) gene: Studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis	1998